This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cameron, H.
Right arrow Articles by Rogers, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cameron, H.
Right arrow Articles by Rogers, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2001, p. 4404-4406, Vol. 39, No. 12
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.12.4404-4406.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Evaluation of the Mycobacterium bovis Restriction Fragment Length Polymorphism Probe pUCD, in Combination with the Direct Repeat Probe, for Molecular Typing of Mycobacterium tuberculosis Strains in Ireland

Henrietta Cameron,1 Rory O'Brien,2 Anthony Murray,1 Bartley Cryan,3 Rosemary Hone,1,* and Mark Rogers2,4

Department of Microbiology, The Mater Misericordiae Hospital, Dublin,1 and Department of Zoology2 and Conway Institute of Biomedical Science,4 University College Dublin, Belfield, Dublin 4, and Department of Microbiology, University Hospital Cork, Wilton,3 Ireland

Received 23 April 2001/Returned for modification 23 July 2001/Accepted 8 October 2001

A mycobacterial restriction fragment length polymorphism probe, pUCD, has recently been described which represents an effective tool for the strain typing of Mycobacterium bovis. The present study evaluated this probe, in combination with the direct repeat probe (DR), for the molecular typing of 90 strains of Mycobacterium tuberculosis from 87 patients, looking at a group (62 isolates) of nonselected samples to assess pUCD combined with DR as a general tool and a subset of 32 isolates with a common specific IS6110 strain type in Ireland. Within the group of 62 isolates, pUCD-DR identified 42 strains and was comparable to both IS6110 (41 strains) and polymorphic guanine-cytosine-rich sequence (PGRS) (37 strains) analysis. pUCD-DR was found to be comparable to IS6110 and PGRS in identifying four separate clusters of isolates which were confirmed to be clinically related. pUCD-DR divided the common IS6110 isolates into six distinct types and was comparable to PGRS (seven strain types). The usefulness of this probe as an epidemiological tool is discussed.


* Corresponding author. Mailing address: Department of Microbiology, The Mater Misericordiae Hospital, Eccles St., Dublin 7. Phone: (353) 1 8032379. Fax: (353) 1 8034781. E-mail: rhone{at}mater.ie.


Journal of Clinical Microbiology, December 2001, p. 4404-4406, Vol. 39, No. 12
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.12.4404-4406.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.